ギランバレー症候群の世界市場（～2026年）

• 英文タイトル：Global Guillain-Barré Syndrome Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12078
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はギランバレー症候群のグローバル市場について調査・分析したレポートです。種類別（静脈内免疫グロブリン、血漿交換、鎮痛薬、抗痙攣薬、LMWH）市場規模、用途別（病院薬局、小売薬局、在宅医療、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ギランバレー症候群の競争状況、市場シェア
・世界のギランバレー症候群市場：種類別市場規模 2015年-2020年（静脈内免疫グロブリン、血漿交換、鎮痛薬、抗痙攣薬、LMWH）
・世界のギランバレー症候群市場：種類別市場規模予測 2021年-2026年（静脈内免疫グロブリン、血漿交換、鎮痛薬、抗痙攣薬、LMWH）
・世界のギランバレー症候群市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、在宅医療、クリニック）
・世界のギランバレー症候群市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、在宅医療、クリニック）
・北米のギランバレー症候群市場分析：米国、カナダ
・ヨーロッパのギランバレー症候群市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのギランバレー症候群市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のギランバレー症候群市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのギランバレー症候群市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Grifols、CSL Behring、Octapharma、Nihon Pharmaceutical、Akari Therapeutics、China Biologic Products Holdings、Biotest、Kedrion
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Guillain-Barré Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.

Market Analysis and Insights: Global Guillain-Barré Syndrome Market
The global Guillain-Barré Syndrome market size is projected to reach US$ 449.2 million by 2026, from US$ 435.9 million in 2020, at a CAGR of 2.8%% during 2021-2026.

Global Guillain-Barré Syndrome Scope and Market Size
Guillain-Barré Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Guillain-Barré Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Grifols
CSL Behring
Octapharma
Nihon Pharmaceutical
Akari Therapeutics
China Biologic Products Holdings
Biotest
Kedrion

Market segment by Type, the product can be split into
Intravenous Immunoglobulin
Plasma Exchange
Analgesics
Anticonvulsants
LMWH
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Home Care
Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Guillain-Barré Syndrome Revenue
1.4 Market by Type
1.4.1 Global Guillain-Barré Syndrome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Intravenous Immunoglobulin
1.4.3 Plasma Exchange
1.4.4 Analgesics
1.4.5 Anticonvulsants
1.4.6 LMWH
1.5 Market by Application
1.5.1 Global Guillain-Barré Syndrome Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Home Care
1.5.5 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Guillain-Barré Syndrome Market Perspective (2015-2026)
2.2 Global Guillain-Barré Syndrome Growth Trends by Regions
2.2.1 Guillain-Barré Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Guillain-Barré Syndrome Historic Market Share by Regions (2015-2020)
2.2.3 Guillain-Barré Syndrome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Guillain-Barré Syndrome Market Growth Strategy
2.3.6 Primary Interviews with Key Guillain-Barré Syndrome Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Guillain-Barré Syndrome Players by Market Size
3.1.1 Global Top Guillain-Barré Syndrome Players by Revenue (2015-2020)
3.1.2 Global Guillain-Barré Syndrome Revenue Market Share by Players (2015-2020)
3.1.3 Global Guillain-Barré Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Guillain-Barré Syndrome Market Concentration Ratio
3.2.1 Global Guillain-Barré Syndrome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Guillain-Barré Syndrome Revenue in 2019
3.3 Guillain-Barré Syndrome Key Players Head office and Area Served
3.4 Key Players Guillain-Barré Syndrome Product Solution and Service
3.5 Date of Enter into Guillain-Barré Syndrome Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Guillain-Barré Syndrome Historic Market Size by Type (2015-2020)
4.2 Global Guillain-Barré Syndrome Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Guillain-Barré Syndrome Market Size by Application (2015-2020)
5.2 Global Guillain-Barré Syndrome Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Guillain-Barré Syndrome Market Size (2015-2020)
6.2 Guillain-Barré Syndrome Key Players in North America (2019-2020)
6.3 North America Guillain-Barré Syndrome Market Size by Type (2015-2020)
6.4 North America Guillain-Barré Syndrome Market Size by Application (2015-2020)

7 Europe
7.1 Europe Guillain-Barré Syndrome Market Size (2015-2020)
7.2 Guillain-Barré Syndrome Key Players in Europe (2019-2020)
7.3 Europe Guillain-Barré Syndrome Market Size by Type (2015-2020)
7.4 Europe Guillain-Barré Syndrome Market Size by Application (2015-2020)

8 China
8.1 China Guillain-Barré Syndrome Market Size (2015-2020)
8.2 Guillain-Barré Syndrome Key Players in China (2019-2020)
8.3 China Guillain-Barré Syndrome Market Size by Type (2015-2020)
8.4 China Guillain-Barré Syndrome Market Size by Application (2015-2020)

9 Japan
9.1 Japan Guillain-Barré Syndrome Market Size (2015-2020)
9.2 Guillain-Barré Syndrome Key Players in Japan (2019-2020)
9.3 Japan Guillain-Barré Syndrome Market Size by Type (2015-2020)
9.4 Japan Guillain-Barré Syndrome Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Guillain-Barré Syndrome Market Size (2015-2020)
10.2 Guillain-Barré Syndrome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Guillain-Barré Syndrome Market Size by Type (2015-2020)
10.4 Southeast Asia Guillain-Barré Syndrome Market Size by Application (2015-2020)

11 India
11.1 India Guillain-Barré Syndrome Market Size (2015-2020)
11.2 Guillain-Barré Syndrome Key Players in India (2019-2020)
11.3 India Guillain-Barré Syndrome Market Size by Type (2015-2020)
11.4 India Guillain-Barré Syndrome Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Guillain-Barré Syndrome Market Size (2015-2020)
12.2 Guillain-Barré Syndrome Key Players in Central & South America (2019-2020)
12.3 Central & South America Guillain-Barré Syndrome Market Size by Type (2015-2020)
12.4 Central & South America Guillain-Barré Syndrome Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Grifols
13.1.1 Grifols Company Details
13.1.2 Grifols Business Overview
13.1.3 Grifols Guillain-Barré Syndrome Introduction
13.1.4 Grifols Revenue in Guillain-Barré Syndrome Business (2015-2020))
13.1.5 Grifols Recent Development
13.2 CSL Behring
13.2.1 CSL Behring Company Details
13.2.2 CSL Behring Business Overview
13.2.3 CSL Behring Guillain-Barré Syndrome Introduction
13.2.4 CSL Behring Revenue in Guillain-Barré Syndrome Business (2015-2020)
13.2.5 CSL Behring Recent Development
13.3 Octapharma
13.3.1 Octapharma Company Details
13.3.2 Octapharma Business Overview
13.3.3 Octapharma Guillain-Barré Syndrome Introduction
13.3.4 Octapharma Revenue in Guillain-Barré Syndrome Business (2015-2020)
13.3.5 Octapharma Recent Development
13.4 Nihon Pharmaceutical
13.4.1 Nihon Pharmaceutical Company Details
13.4.2 Nihon Pharmaceutical Business Overview
13.4.3 Nihon Pharmaceutical Guillain-Barré Syndrome Introduction
13.4.4 Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2015-2020)
13.4.5 Nihon Pharmaceutical Recent Development
13.5 Akari Therapeutics
13.5.1 Akari Therapeutics Company Details
13.5.2 Akari Therapeutics Business Overview
13.5.3 Akari Therapeutics Guillain-Barré Syndrome Introduction
13.5.4 Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2015-2020)
13.5.5 Akari Therapeutics Recent Development
13.6 China Biologic Products Holdings
13.6.1 China Biologic Products Holdings Company Details
13.6.2 China Biologic Products Holdings Business Overview
13.6.3 China Biologic Products Holdings Guillain-Barré Syndrome Introduction
13.6.4 China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2015-2020)
13.6.5 China Biologic Products Holdings Recent Development
13.7 Biotest
13.7.1 Biotest Company Details
13.7.2 Biotest Business Overview
13.7.3 Biotest Guillain-Barré Syndrome Introduction
13.7.4 Biotest Revenue in Guillain-Barré Syndrome Business (2015-2020)
13.7.5 Biotest Recent Development
13.8 Kedrion
13.8.1 Kedrion Company Details
13.8.2 Kedrion Business Overview
13.8.3 Kedrion Guillain-Barré Syndrome Introduction
13.8.4 Kedrion Revenue in Guillain-Barré Syndrome Business (2015-2020)
13.8.5 Kedrion Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Guillain-Barré Syndrome Key Market Segments
Table 2. Key Players Covered: Ranking by Guillain-Barré Syndrome Revenue
Table 3. Ranking of Global Top Guillain-Barré Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Guillain-Barré Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intravenous Immunoglobulin
Table 6. Key Players of Plasma Exchange
Table 7. Key Players of Analgesics
Table 8. Key Players of Anticonvulsants
Table 9. Key Players of LMWH
Table 10. Global Guillain-Barré Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Guillain-Barré Syndrome Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Guillain-Barré Syndrome Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Guillain-Barré Syndrome Market Share by Regions (2015-2020)
Table 14. Global Guillain-Barré Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Guillain-Barré Syndrome Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Guillain-Barré Syndrome Market Growth Strategy
Table 20. Main Points Interviewed from Key Guillain-Barré Syndrome Players
Table 21. Global Guillain-Barré Syndrome Revenue by Players (2015-2020) (Million US$)
Table 22. Global Guillain-Barré Syndrome Market Share by Players (2015-2020)
Table 23. Global Top Guillain-Barré Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guillain-Barré Syndrome as of 2019)
Table 24. Global Guillain-Barré Syndrome by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Guillain-Barré Syndrome Product Solution and Service
Table 27. Date of Enter into Guillain-Barré Syndrome Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Guillain-Barré Syndrome Market Size by Type (2015-2020) (Million US$)
Table 30. Global Guillain-Barré Syndrome Market Size Share by Type (2015-2020)
Table 31. Global Guillain-Barré Syndrome Revenue Market Share by Type (2021-2026)
Table 32. Global Guillain-Barré Syndrome Market Size Share by Application (2015-2020)
Table 33. Global Guillain-Barré Syndrome Market Size by Application (2015-2020) (Million US$)
Table 34. Global Guillain-Barré Syndrome Market Size Share by Application (2021-2026)
Table 35. North America Key Players Guillain-Barré Syndrome Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Guillain-Barré Syndrome Market Share (2019-2020)
Table 37. North America Guillain-Barré Syndrome Market Size by Type (2015-2020) (Million US$)
Table 38. North America Guillain-Barré Syndrome Market Share by Type (2015-2020)
Table 39. North America Guillain-Barré Syndrome Market Size by Application (2015-2020) (Million US$)
Table 40. North America Guillain-Barré Syndrome Market Share by Application (2015-2020)
Table 41. Europe Key Players Guillain-Barré Syndrome Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Guillain-Barré Syndrome Market Share (2019-2020)
Table 43. Europe Guillain-Barré Syndrome Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Guillain-Barré Syndrome Market Share by Type (2015-2020)
Table 45. Europe Guillain-Barré Syndrome Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Guillain-Barré Syndrome Market Share by Application (2015-2020)
Table 47. China Key Players Guillain-Barré Syndrome Revenue (2019-2020) (Million US$)
Table 48. China Key Players Guillain-Barré Syndrome Market Share (2019-2020)
Table 49. China Guillain-Barré Syndrome Market Size by Type (2015-2020) (Million US$)
Table 50. China Guillain-Barré Syndrome Market Share by Type (2015-2020)
Table 51. China Guillain-Barré Syndrome Market Size by Application (2015-2020) (Million US$)
Table 52. China Guillain-Barré Syndrome Market Share by Application (2015-2020)
Table 53. Japan Key Players Guillain-Barré Syndrome Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Guillain-Barré Syndrome Market Share (2019-2020)
Table 55. Japan Guillain-Barré Syndrome Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Guillain-Barré Syndrome Market Share by Type (2015-2020)
Table 57. Japan Guillain-Barré Syndrome Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Guillain-Barré Syndrome Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Guillain-Barré Syndrome Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Guillain-Barré Syndrome Market Share (2019-2020)
Table 61. Southeast Asia Guillain-Barré Syndrome Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Guillain-Barré Syndrome Market Share by Type (2015-2020)
Table 63. Southeast Asia Guillain-Barré Syndrome Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Guillain-Barré Syndrome Market Share by Application (2015-2020)
Table 65. India Key Players Guillain-Barré Syndrome Revenue (2019-2020) (Million US$)
Table 66. India Key Players Guillain-Barré Syndrome Market Share (2019-2020)
Table 67. India Guillain-Barré Syndrome Market Size by Type (2015-2020) (Million US$)
Table 68. India Guillain-Barré Syndrome Market Share by Type (2015-2020)
Table 69. India Guillain-Barré Syndrome Market Size by Application (2015-2020) (Million US$)
Table 70. India Guillain-Barré Syndrome Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Guillain-Barré Syndrome Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Guillain-Barré Syndrome Market Share (2019-2020)
Table 73. Central & South America Guillain-Barré Syndrome Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Guillain-Barré Syndrome Market Share by Type (2015-2020)
Table 75. Central & South America Guillain-Barré Syndrome Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Guillain-Barré Syndrome Market Share by Application (2015-2020)
Table 77. Grifols Company Details
Table 78. Grifols Business Overview
Table 79. Grifols Product
Table 80. Grifols Revenue in Guillain-Barré Syndrome Business (2015-2020) (Million US$)
Table 81. Grifols Recent Development
Table 82. CSL Behring Company Details
Table 83. CSL Behring Business Overview
Table 84. CSL Behring Product
Table 85. CSL Behring Revenue in Guillain-Barré Syndrome Business (2015-2020) (Million US$)
Table 86. CSL Behring Recent Development
Table 87. Octapharma Company Details
Table 88. Octapharma Business Overview
Table 89. Octapharma Product
Table 90. Octapharma Revenue in Guillain-Barré Syndrome Business (2015-2020) (Million US$)
Table 91. Octapharma Recent Development
Table 92. Nihon Pharmaceutical Company Details
Table 93. Nihon Pharmaceutical Business Overview
Table 94. Nihon Pharmaceutical Product
Table 95. Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2015-2020) (Million US$)
Table 96. Nihon Pharmaceutical Recent Development
Table 97. Akari Therapeutics Company Details
Table 98. Akari Therapeutics Business Overview
Table 99. Akari Therapeutics Product
Table 100. Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2015-2020) (Million US$)
Table 101. Akari Therapeutics Recent Development
Table 102. China Biologic Products Holdings Company Details
Table 103. China Biologic Products Holdings Business Overview
Table 104. China Biologic Products Holdings Product
Table 105. China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2015-2020) (Million US$)
Table 106. China Biologic Products Holdings Recent Development
Table 107. Biotest Company Details
Table 108. Biotest Business Overview
Table 109. Biotest Product
Table 110. Biotest Revenue in Guillain-Barré Syndrome Business (2015-2020) (Million US$)
Table 111. Biotest Recent Development
Table 112. Kedrion Business Overview
Table 113. Kedrion Product
Table 114. Kedrion Company Details
Table 115. Kedrion Revenue in Guillain-Barré Syndrome Business (2015-2020) (Million US$)
Table 116. Kedrion Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Guillain-Barré Syndrome Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Immunoglobulin Features
Figure 3. Plasma Exchange Features
Figure 4. Analgesics Features
Figure 5. Anticonvulsants Features
Figure 6. LMWH Features
Figure 7. Global Guillain-Barré Syndrome Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Home Care Case Studies
Figure 11. Clinics Case Studies
Figure 12. Guillain-Barré Syndrome Report Years Considered
Figure 13. Global Guillain-Barré Syndrome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Guillain-Barré Syndrome Market Share by Regions: 2020 VS 2026
Figure 15. Global Guillain-Barré Syndrome Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Guillain-Barré Syndrome Market Share by Players in 2019
Figure 18. Global Top Guillain-Barré Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guillain-Barré Syndrome as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Guillain-Barré Syndrome Revenue in 2019
Figure 20. North America Guillain-Barré Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Guillain-Barré Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Guillain-Barré Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Guillain-Barré Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Guillain-Barré Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Guillain-Barré Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Guillain-Barré Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

以下、関連資料のご紹介

ギランバレー症候群治療薬の世界市場（～2026年）

Global Guillain-Barre Syndrome Drugs Market Insights and Forecast to 2026
MRC2-11QY07010 2020年11月20日 112Pages
当調査資料はギランバレー症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（余矢、免疫グロブリン、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

携帯型バレエバレの世界市場（～2026年）

Global Portable Ballet Barre Market Insights and Forecast to 2026
MRC2-11QY14176 2020年11月30日 117Pages
当調査資料は携帯型バレエバレのグローバル市場について調査・分析したレポートです。種類別（金属、木材、その他）市場規模、用途別（家庭、商業）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メ...

間欠的発熱症候群の世界市場（～2026年）

Global Periodic Fever Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY04216 2020年11月20日 98Pages
当調査資料は間欠的発熱症候群のグローバル市場について調査・分析したレポートです。種類別（高IGE D症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）市場規模、用途別（病院、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

ドラベ症候群治療の世界市場（～2026年）

Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11711 2020年11月25日 97Pages
当調査資料はドラベ症候群治療のグローバル市場について調査・分析したレポートです。種類別（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

吸収不良症候群の世界市場（～2026年）

Global Malabsorption Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY12575 2020年11月25日 93Pages
当調査資料は吸収不良症候群のグローバル市場について調査・分析したレポートです。種類別（乳糖不耐症、嚢胞性線維症、ウィップル病、寄生虫症、熱帯性スプルー、腸障害）市場規模、用途別（製薬会社、病院、栄養クリニック、学術研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

チャーグ・ストラウス症候群の世界市場（～2026年）

Global Churg Strauss Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY11375 2020年11月25日 95Pages
当調査資料はチャーグ・ストラウス症候群のグローバル市場について調査・分析したレポートです。種類別（生物製剤、免疫グロブリン、ワクチン、ステロイド、その他）市場規模、用途別（研究所、病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

パリーロンバーグ病の世界市場（～2026年）

Global Parry-Romberg Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY04167 2020年11月20日 96Pages
当調査資料はパリーロンバーグ病のグローバル市場について調査・分析したレポートです。種類別（健康診断、MRIスキャン、血清検査）市場規模、用途別（病院＆クリニック、理学療法士）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

バーター症候群治療の世界市場（～2026年）

Global Bartter Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11022 2020年11月25日 96Pages
当調査資料はバーター症候群治療のグローバル市場について調査・分析したレポートです。種類別（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬...

多嚢胞性卵巣症候群治療の世界市場（～2026年）

Global Polycystic Ovarian Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04319 2020年11月20日 98Pages
当調査資料は多嚢胞性卵巣症候群治療のグローバル市場について調査・分析したレポートです。種類別（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤およびSERM、利尿剤）市場規模、用途別（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック）市場規模、...

クッシング症候群治療の世界市場（～2026年）

Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11542 2020年11月25日 96Pages
当調査資料はクッシング症候群治療のグローバル市場について調査・分析したレポートです。種類別（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

ギランバレー症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Guillain-Barre Syndrome Drugs Market The global Guillain-Barre Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Guillain-Barre Syndrome Drugs Scope and Market Size Gui…
携帯型バレエバレの世界市場（～2026年） Market Analysis and Insights: Global Portable Ballet Barre Market The global Portable Ballet Barre market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Portable Ballet Barre Scope and Market Size Portable Ballet Barre marke…
バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
クッシング症候群治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of…